|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
City | WASHINGTON |
State | DC |
Zip Code | 20001-7400 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Chicago |
State | IL |
Zip Code | 60611 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
TYPE OF REPORT | 8. Year | 2014 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: GEORGE E. COX III, JD |
Date | 1/20/2015 5:11:31 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
H.R. 4282, Creating Access to Residency Education Act of 2014, all provisions
H.R. 1180, Resident Physician Shortage Reduction Act of 2013, all provisions
S. 577, Resident Physician Shortage Reduction Act of 2013, all provisions
Graduate Medical Education
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S. 2839, Comprehensive Addiction and Recovery Act of 2014, all provisions
S. 2645, Recovery Enhancement for Addiction Treatment (TREAT) Act, all provisions
H.R. 5481, To continue the use of a 3-month quarter EHR reporting period for health care providers to demonstrate meaningful use for 2015 under the Medicare and Medicaid EHR incentive payment programs, and for other purposes, all provisions
H.R. 1074, National Diabetes Clinical Care Commission Act, all provisions
S. 539, National Diabetes Clinical Care Commission Act, all provisions
H.R. 1701, Cutting Costly Codes Act of 2013, all provisions
S. 972, Cutting Costly Codes Act of 2013, all provisions
Affordable Care Act - implementation
Ebola
Prescription requirements for OTC medications
Electronic Health Records - Meaningful Use
ICD-10 Repeal
Prescription Drug Diversion
Prescription drug abuse/pain management/prescriber education
Telemedicine
Sunshine Act
Laboratory Developed Tests
21st Century Cures Initiative
Narrow Networks
Mental Health
Diabetes
Antibiotics and data collection
Personalized medicine
Coverage of lung cancer screening for high-risk patients
Drug Quality and Security Act/Compounded and Repackaged Medications
Federal scientists and researchers - academic and scientific conference travel restrictions
Men who have sex with men/blood donor deferral policy
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Disease Control & Prevention (CDC), White House Office, Substance Abuse & Mental Health Services Administration (SAMHSA), Office of Natl Drug Control Policy (NDCP), Food & Drug Administration (FDA), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Mari |
Savickis |
|
|
|
Jason |
Scull |
|
|
|
Cybil |
Roehrenbeck |
|
|
|
George |
Cox |
III |
|
|
Eileen |
Carlson |
|
|
|
Debra |
Cohn |
|
|
|
Kristen |
O'Brien |
|
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
Antitrust
Medical Licensure
Meaningful Use - Data Lock-in
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, Federal Trade Commission (FTC), Justice - Dept of (DOJ)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Margaret |
Garikes |
|
|
|
Matthew |
Reid |
|
|
|
Cybil |
Roehrenbeck |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 4015, SGR Repeal and Medicare Provider Payment Modernization Act of 2014, all provisions
S. 2000, SGR Repeal and Medicare Provider Payment Modernization Act of 2014, all provisions
H.R. 1179, Improving Access to Medicare Coverage Act of 2013, all provisions
S. 569, Improving Access to Medicare Coverage Act of 2013, all provisions
H.R. 647, Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014), provisions relating to Misvalued Codes
S. 313, Achieving a Better Life Experience Act of 2013 (ABLE Act of 2013), provisions relating to Misvalued Codes
H.R. 962, Medicare Diabetes Prevention Act of 2013, all provisions
S. 452, Medicare Diabetes Prevention Act of 2013, all provisions
H.R. 4282, Creating Access to Residency Education Act of 2014, all provisions
H.R. 4843, Native Contract and Rate Expenditure Act of 2014 (Native CARE Act of 2014), all provisions
H.R. 5481, To continue the use of a 3-month quarter EHR reporting period for health care providers to demonstrate meaningful use for 2015 under the Medicare and Medicaid EHR incentive payment programs, and for other purposes, all provisions
H.R. 4998, Medicare Advantage Participant Bill of Rights Act of 2014, all provisions
S. 2552, Medicare Advantage Participant Bill of Rights Act of 2014, all provisions
H.R. 1180, Resident Physician Shortage Reduction Act of 2013, all provisions
S. 577, Resident Physician Shortage Reduction Act of 2013, all provisions
S. 1180, Medicare Data Access for Transparency and Accountability Act, all provisions
S. 2501, Hospital Readmissions Program Accuracy and Accountability Act of 2014, all provisions
H.R. 5723, Ensuring Access to Primary Care for Women & Children Act, all provisions
S. 2694, Ensuring Access to Primary Care for Women & Children Act, all provisions
H.R. 5780, Protecting the Integrity of Medicare Act (PIMA) of 2014, all provisions
H.R. 4302, Protecting Access to Medicare Act of 2014, provisions relating to coding and pricing issues
Medicare program: SGR Repeal
Medicare program: Independent Payment Advisory Board (IPAB) Repeal
Medicare program: Medicare Patient Empowerment Act
Medicare program: Graduate Medical Education
Medicare program: ICD-10 Repeal
Medicare program: Overlapping Medicare incentive programs
Medicare program: HIPAA including ICD-10
Medicare program: Electronic Health Records (EHR) - Meaningful Use
Medicare program: EHR Certification
Medicare program: Physician Quality Reporting System (PQRS)
Medicare program: Laboratory Developed Tests
Medicare program: Alternative Payment Models/quality performance measures
Medicare program: Physician payment and delivery reform issues
Medicare program: Hospital short stay
Medicare program: Medicare funding for quality measure development
Medicare program: Value-Based Modifiers
Medicare program: Global Surgical Codes
Medicare program: In-Office Ancillary Services Exception
Medicare program: RUC - Misvalued and Care Coordination Codes
Medicare program: Diabetes
Medicare program: Recovery Audit Contractors
Medicare program: Program Integrity - Meaningful Use Audits
Medicare program: Program Integrity - Modifiers
Medicare program: Program Integrity - Electronic Health Records
Medicare and Medicaid programs: Coverage of lung cancer screening for high-risk patients
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), White House Office, Food & Drug Administration (FDA), Medicare Payment Advisory Commission (MedPAC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Mari |
Savickis |
|
|
|
Jason |
Scull |
|
|
|
Cybil |
Roehrenbeck |
|
|
|
George |
Cox |
III |
|
|
Eileen |
Carlson |
|
|
|
Debra |
Cohn |
|
|
|
Kristen |
O'Brien |
|
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
H.R. 1733, Good Samaritan Health Professionals Act of 2013, all provisions
S. 2196, Good Samaritan Health Professionals Act of 2014, all provisions
H.R. 1473, Standard of Care Protection Act of 2013, all provisions
S. 1769, Standard of Care Protection Act, all provisions
H.R. 4106, Saving Lives, Saving Costs Act, all provisions
Medical Liability Reform
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
|
Jason |
Marino |
|
|
|
Andrew |
Wankum |
|
|
|
George |
Cox |
III |
|
|
Kristen |
O'Brien |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
House Committee on Appropriations Report 113-416 accompanying H.R. 4486, the Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2015, provisions relating to the draft Veterans Health Administration Handbook
Veterans Affairs Reform
Veterans Choice Program
Federal scientists and researchers - academic and scientific conference travel restrictions
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
|
Jason |
Marino |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 83, The Consolidated and Further Continuing Appropriations Act, 2015, provisions relating to Global Surgical Services Code Changes
Indian Health Services (HIS) funding issues
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
George |
Cox |
III |
|
|
Eileen |
Carlson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
TOB |
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |